pravastatin has been researched along with Chronic Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baimbridge, C; Barzilay, JI; Basile, JN; Davis, BR; Henriquez, MA; Huml, A; Kopyt, N; Louis, GT; Pressel, SL; Rahman, M; Rosendorff, C; Sastrasinh, S; Stanford, C | 1 |
| Fledderus, JO; Giles, RH; Gremmels, H; Joles, JA; Oosterhuis, NR; Papazova, DA; van Koppen, A; Verhaar, MC | 1 |
| Bussolati, B; Grange, C | 1 |
| Deedwania, PC; Fayyad, RS; Laskey, RE; Stone, PH; Wilson, DJ | 1 |
| Adema, AY; de Borst, MH; Heijboer, AC; Hoenderop, JG; Nanayakkara, PW; Ter Wee, PM; van Ittersum, FJ; Vervloet, MG | 1 |
| Craven, T; Curhan, G; Furberg, C; Isles, C; Keech, A; Packard, C; Pfeffer, M; Sacks, F; Shepherd, J; Simes, J; Tonelli, M; Tonkin, A; West, M | 1 |
4 trial(s) available for pravastatin and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
Topics: Aged; Coronary Disease; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Prospective Studies; Renal Insufficiency, Chronic; Survival Rate; Time Factors; Treatment Outcome; United States | 2013 |
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
Topics: Aged; Aged, 80 and over; Atorvastatin; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pravastatin; Renal Insufficiency, Chronic; Uric Acid | 2015 |
Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Biomarkers; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Glucuronidase; Humans; Klotho Proteins; Male; Middle Aged; Oxidative Stress; Pravastatin; Renal Insufficiency, Chronic; Renin-Angiotensin System; Vitamin E; Young Adult | 2016 |
Effect of pravastatin in people with diabetes and chronic kidney disease.
Topics: Adult; Age Distribution; Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Prevalence; Probability; Prognosis; Renal Insufficiency, Chronic; Risk Assessment; Sex Distribution; Treatment Outcome | 2005 |
2 other study(ies) available for pravastatin and Chronic Kidney Diseases
| Article | Year |
|---|---|
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.
Topics: Animals; Apoptosis; Blood Pressure; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Chemokine CXCL5; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pravastatin; Rats; Rats, Inbred Lew; Renal Insufficiency, Chronic; Tissue Donors; Transplantation, Homologous | 2015 |
Ex vivo manipulation of bone marrow cells to rescue uremia-induced dysfunction for autologous therapy.
Topics: Animals; Bone Marrow Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Renal Insufficiency, Chronic | 2015 |